• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

aVR 导联 T 波正向对预测肥厚型心肌病患者心律失常事件和死亡率的作用。

Usefulness of positive T wave in lead aVR in predicting arrhythmic events and mortality in patients with hypertrophic cardiomyopathy.

机构信息

Department of Cardiology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey.

Department of Cardiology, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey.

出版信息

Heart Rhythm. 2020 Aug;17(8):1312-1319. doi: 10.1016/j.hrthm.2020.03.030. Epub 2020 Apr 14.

DOI:10.1016/j.hrthm.2020.03.030
PMID:32302704
Abstract

BACKGROUND

Positive T wave in lead aVR (TaVR) has been associated with increased risk of adverse events in patients with various cardiovascular diseases.

OBJECTIVE

The purpose of this study was to investigate the prevalence and prognostic significance of positive TaVR in patients with hypertrophic cardiomyopathy (HCM).

METHODS

This study investigated 421 consecutive patients with HCM (177 women; age 51.1 ± 14.9 years). Admission electrocardiogram was examined for the presence of a positive TaVR. The primary endpoint was defined as a composite of major arrhythmic events (MAEs), which included sudden cardiac death, sustained ventricular tachycardia or fibrillation, or appropriate implantable cardioverter-defibrillator therapy. Cardiovascular mortality and all-cause death were evaluated as secondary endpoints.

RESULTS

During median follow-up period of 6.0 years (interquartile range 4.0-11.6 years), 53 patients (12.6%) experienced the primary endpoint. On multivariable competing analysis, after adjusting for other confounding factors, the presence of positive TaVR was found to be an independent and strong predictor of the primary composite endpoint. Time-dependent receiver operating characteristic analysis, net reclassification index, and integrated discrimination improvement showed that the addition of positive TaVR to conventional HCM risk factors improved prediction of arrhythmic events. However, in subgroup analysis, a positive TaVR lost statistical significance in patients with apical HCM but remained significant in patients with all other hypertrophy patterns.

CONCLUSION

Positive TaVR is associated with MAE in HCM patients, independent of and incremental to traditional risk factors.

摘要

背景

在患有各种心血管疾病的患者中,aVR 导联的正向 T 波(TaVR)与不良事件风险增加相关。

目的

本研究旨在探讨肥厚型心肌病(HCM)患者中 TaVR 阳性的患病率和预后意义。

方法

本研究纳入了 421 例连续的 HCM 患者(女性 177 例;年龄 51.1±14.9 岁)。检查入院心电图是否存在 TaVR 阳性。主要终点定义为主要心律失常事件(MAEs)的复合终点,包括心源性猝死、持续性室性心动过速或颤动、或适当的植入式心脏复律除颤器治疗。心血管死亡率和全因死亡率被评估为次要终点。

结果

在中位随访 6.0 年期间(四分位间距 4.0-11.6 年),53 例患者(12.6%)发生了主要终点。在多变量竞争分析中,在调整其他混杂因素后,TaVR 阳性被发现是主要复合终点的独立且强有力的预测因素。时间依赖性受试者工作特征曲线分析、净重新分类指数和综合判别改善表明,将 TaVR 阳性加入传统的 HCM 危险因素可改善心律失常事件的预测。然而,在亚组分析中,在心尖型 HCM 患者中 TaVR 阳性失去统计学意义,但在所有其他肥厚模式的患者中仍有意义。

结论

TaVR 阳性与 HCM 患者的 MAE 相关,独立于且增加了传统的危险因素。

相似文献

1
Usefulness of positive T wave in lead aVR in predicting arrhythmic events and mortality in patients with hypertrophic cardiomyopathy.aVR 导联 T 波正向对预测肥厚型心肌病患者心律失常事件和死亡率的作用。
Heart Rhythm. 2020 Aug;17(8):1312-1319. doi: 10.1016/j.hrthm.2020.03.030. Epub 2020 Apr 14.
2
Importance of lead aVR on predicting adverse cardiac events in patients with noncompaction cardiomyopathy.左前斜位 Lead aVR 对非致密性心肌病患者不良心脏事件的预测价值。
Ann Noninvasive Electrocardiol. 2020 May;25(3):e12719. doi: 10.1111/anec.12719. Epub 2019 Oct 14.
3
QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.QRS波离散度和QTc间期与肥厚型心肌病患者的恶性室性心律失常及心源性猝死相关。
J Cardiovasc Electrophysiol. 2015 May;26(5):547-55. doi: 10.1111/jce.12629. Epub 2015 Mar 27.
4
J Waves for Predicting Cardiac Events in Hypertrophic Cardiomyopathy.J 波预测肥厚型心肌病的心脏事件。
JACC Clin Electrophysiol. 2017 Oct;3(10):1136-1142. doi: 10.1016/j.jacep.2017.03.010. Epub 2017 Jun 28.
5
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.非梗阻性、易变型和梗阻性肥厚型心肌病患者的临床转归。
J Am Heart Assoc. 2018 Feb 25;7(5):e006657. doi: 10.1161/JAHA.117.006657.
6
The prognostic value of positive T wave in lead aVR: A novel marker of adverse cardiac outcomes in peripartum cardiomyopathy.aVR导联T波阳性的预后价值:围产期心肌病不良心脏结局的一种新标志物。
Ann Noninvasive Electrocardiol. 2019 May;24(3):e12631. doi: 10.1111/anec.12631. Epub 2019 Jan 17.
7
Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy.碎裂QRS波作为肥厚型心肌病高危评估的候选标志物。
Heart Rhythm. 2014 Aug;11(8):1433-40. doi: 10.1016/j.hrthm.2014.05.002. Epub 2014 May 6.
8
Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者心脏磁共振成像显示的弥漫性心室纤维化与室性心动过速相关。
J Cardiovasc Electrophysiol. 2016 May;27(5):571-80. doi: 10.1111/jce.12948. Epub 2016 Mar 14.
9
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.肥厚型心肌病和植入式心脏复律除颤器高危患者的临床过程和生活质量。
Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005820. doi: 10.1161/CIRCEP.117.005820.
10
Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.植入式心脏复律除颤器治疗与肥厚型心肌病合并心室中部梗阻患者的猝死风险分层:单中心经验
Int J Cardiol. 2016 Jul 1;214:419-22. doi: 10.1016/j.ijcard.2016.03.231. Epub 2016 Apr 4.

引用本文的文献

1
[Arrhythmias and Sudden Death Risk in Hypertrophic Cardiomyopathy].[肥厚型心肌病中的心律失常与猝死风险]
Arch Peru Cardiol Cir Cardiovasc. 2020 Jun 29;1(2):94-104. doi: 10.47487/apcyccv.v1i2.41. eCollection 2020 Apr-Jun.
2
Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers.左心室肥厚与室性心律失常:生物标志物的作用。
Int J Mol Sci. 2023 Feb 15;24(4):3881. doi: 10.3390/ijms24043881.